Dr. Nick Proctor

Understanding Pharma Market Access & Payers in Europe

With Dr Nick Proctor

Course Details

THE CONTENT

Market access is essential for brand success yet achieving it in Europe’s complex and evolving healthcare systems is far from straightforward. Each country has its own structure, payer expectations, and decision-making processes. Navigating these effectively requires careful planning and cross-functional collaboration from Phase II onwards.

This course is designed to demystify market access in Europe. You will receive clear schematic overviews of the market access systems in Europe’s major markets (EU4+UK), providing you with a reliable reference tool for your day-to-day work. The content will help you understand how access decisions are made and what is required to optimise market access from early development onwards.
 

I gained a solid understanding of the material and deeper insights into the top 5 EU countries, including payer evaluations and what their needs are per country. Nick was a very thoughtful teacher who answered all my questions and was patient and very knowledgeable on each topic. Recommended!

Johnson & Johnson

Neha D. - USA - March 2025


Hear directly from expert Nick Proctor why you should attend this course:


THE EXPERT

Dr Nick Proctor has been a trusted advisor on market access to the pharmaceutical industry for over 25 years, leading pricing, reimbursement, and market access projects for many of the world’s top pharmaceutical brands.

  • He is a Partner at Access Infinity, a specialist pharma market access and pricing consultancy.

  • He has a strong background in pricing, evidence synthesis, health economics and outcomes research, as well as experience working with payers in all major developed and emerging international health markets.

  • A CELforPharma faculty member since 2015, Nick is a very passionate trainer. He actively engages participants in discussions and is highly experienced in leading interactive sessions.
     

A clear helicopter view of the Market Access environment in Europe! I recommend this course to anyone seeking a better understanding of the Market Access process and how payers assess drugs. Nick is a great expert and trainer.

Molteni Farmaceutici

Filippo Mannelli, Portfolio & Business Development Manager - Italy - March 2025


THE AUDIENCE & INTERACTIVE LEARNING FORMAT

If you contribute to optimising market access for new chemical entities or innovator drugs, this course is designed for you. It is particularly relevant for professionals working in Market Access, Medical Affairs, Marketing, Clinical Development, and Health Outcomes.

You will benefit from:

  • Expert-led explanations of European market access systems, with clear schematic overviews

  • Opportunities to ask your specific questions and receive personalised guidance

  • Peer learning through open discussion and shared experiences

This format ensures you leave with a solid understanding of how market access works across Europe and how payers assess new drugs.

If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend. 

  1. The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.

  2. Market access challenges and opportunities in these countries.

  3. How to differentiate between different categories of payers.

  4. Payer archetypes and the drivers of their decision-making processes.

  5. The market access plan and process, and the contributions of internal stakeholders across functions.

  6. The types of Managed Entry Agreements used by payers and pharma to mitigate risk.

Course agenda

 

This course was well-structured and informative, and Nick was able to provide answers to all questions. I also liked the cross-country attendance and interactions with the other participants.

Eisai

Chiara Castellarin, Associate Brand Director EMEA - United Kingdom/Europe - March 2025

 

 

 

Welcome & Introductions (~30 min)
Demystifying Market Access (~1 h)
  • What do we mean by market access? What does it encompass?
  • Why and how did market access evolve?
  • What are the concerns of market access decision-makers?
Understanding Payer Archetypes (~2 h)
  • What are the useful ways of thinking about different types of payers?
  • The three universal drivers of payer value
  • The three approaches to archetyping payers, illustrated by examples in Europe
  • The strengths and weaknesses of different payer archetype approaches
  • How to decide which approach to use in a particular situation
  • The common missteps and challenges when applying payer archetypes
  • How to successfully use payer archetypes to plan evidence development
Lunch Break
France & Germany (~1 h 15 min)
  • Understanding national payer assessment processes and implications in France and Germany
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries
Italy & Spain (~45 min)
  • Understanding national payer assessment processes and implications in Italy and Spain
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries
UK (~30 min)
  • Understanding national payer assessment processes and implications in the UK
  • Critical stakeholders in the UK
  • Market access challenges and opportunities in the UK
A Cross-functional Process for Optimal Access (~45 min)
  • The market access plan and process as of Phase II
  • Milestones and the critical contributions of internal stakeholders
  • Different types of Managed Entry Agreements illustrated by real-world examples
Final Q&A (~15 min)

 

Download Brochure

 

Complete the below form to download the full course brochure. It outlines the detailed agenda, learning outcomes, expert info and some testimonials from past participants.

 

 

UPCOMING DATES & FORMATS - FEES

3 October 2025

Live online (CET timing)

Early bird € 1 470

(until 29/08/2025)

(Full fee € 1 670)

10 December 2025

Live online (CET timing)

Early bird € 1 470

(until 07/11/2025)

(Full fee € 1 670)

 


TIMING & LOCATION

  • Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).

  • Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).

  • Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.

All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .

 

GROUP DISCOUNTS

Team discounts can be offered to 2 or more delegates from the same company.

Email Annelies Swaan, Director Business Operations, for more details. 

 

HOW TO REGISTER

  • Click the green “Register” button on your preferred course session.
    The registration wizard will guide you through the process.

  • Alternatively, download the offline registration form and send the completed form to Annelies Swaan.

 

PAYMENT OPTIONS

  • Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).

  • Bank Transfer: Details provided with your invoice.

For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.

 

INCLUDED IN THE REGISTRATION FEE

  • Access to a highly interactive, small-group online course (max 20 participants)

  • Course materials in both digital and hard copy format

  • Certificate of attendance signed by the experts and CELforPharma

 

VAT INFORMATION

Prices exclude VAT. VAT application depends on course format and your location:

  • Face-to-Face in Belgium: 21% Belgian VAT applies

  • Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.

 

TRANSFER & CANCELLATION POLICY

Flexible Transfer

If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.

Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.

Registration Cancellation

  • Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.

  • Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.

  • More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.

If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
 

The average Recommendation Score from participants of the last session was 

9,4/10!

 

 

Testimonials from past participants:

Very comprehensive information, including background and historical explanations.

Bayer Vital

Valeska Irrgang, Portfolio Strategist Europe - Germany - March 2025

A clear helicopter view of the Market Access environment in Europe! I recommend this course to anyone seeking a better understanding of the Market Access process and how payers assess drugs. Nick is a great expert and trainer.

Molteni Farmaceutici

Filippo Mannelli, Portfolio & Business Development Manager - Italy - March 2025

This course was well-structured and informative, and Nick was able to provide answers to all questions. I also liked the cross-country attendance and interactions with the other participants.

Eisai

Chiara Castellarin, Associate Brand Director EMEA - United Kingdom/Europe - March 2025

I gained a solid understanding of the material and deeper insights into the top 5 EU countries, including payer evaluations and what their needs are per country. Nick was a very thoughtful teacher who answered all my questions and was patient and very knowledgeable on each topic. Recommended!

Johnson & Johnson

Neha D. - USA - March 2025

The Understanding Pharma Market Access & Payers in Europe course was a great way to enhance the understanding of access principles for those new to or outside the field of market access. The course was well-structured, and participants shared valuable real-life insights from their various companies and functions.

Novartis

Sonia Adda, AD, Breast Cancer Marketing - Switzerland - December 2024

As someone who has been working in pharma for the past 10 years but not in the market access space, this course gave me a rich understanding of the market access process, its complexities, and its role in enabling pharmaceutical products to reach patients. Thank you!

Ferring

Sonia Johnston, VP HR (Global Science & Medical Organisation) - Switzerland - December 2024

A very engaging course that is relevant to a broad audience, both within the market access function and outside of it. Highly recommended!

Vertex

Yana Berezovskaya, Senior Medical Science Liaison - United Kingdom - December 2024

Comprehensive, high-level view of Market Access, in particular a focus on payer archetypes and what motivates them. This course really does explain the why behind many Market Access-related decisions. I was glad to have the live course where I could ask questions in real-time and hear from others. Thank you!

CSL

Sarah Hamlett, Senior Director, Global Head of Payer Partnerships - Switzerland - October 2024

Interesting course where I had the opportunity to learn about the several routes of access in Europe in the different countries.

FarmaMondo

Luigi Bocchetti, Market Access Manager - Italy - October 2024

Useful for putting ourselves in the shoes of a payer!

Almirall

Rituparna Banerjee, Global Market Access Senior Manager - Spain - October 2024

Nick was great! Very informative and helpful session!

Medreich

Ruchika Raisinghani, Business Development Manager - United Kingdom - October 2024

I recently completed the "Understanding Pharma Market Access & Payers in Europe" course, and I must say it exceeded my expectations. The explanations provided were very clear, accompanied by relevant examples that made the complex concepts easy to grasp. The course offered valuable insights into the intricacies of pharma market access and payer dynamics in Europe. I highly recommend it to anyone looking to enhance their understanding of this critical aspect of the pharmaceutical industry.

EFPIA

Giacomo Borgo, Associate Director Public Affairs - Belgium - December 2023

Very informative session facilitated by an industry expert. Highly recommended if you want to know more on EU payers.

Boehringer Ingelheim

Hans Demeyere, Senior Manager Global Market Access - Germany - September 2023

Having worked in access positions for few months now, this course enabled me to structure my knowledge while filling the gaps. I recommend it for any newcomer in an Access and Pricing role.

UCB

Nicolas De Mot, Market Access Performance Lead - Belgium - September 2023

I am very pleased with the course! The information shared definitely gave me a direction on how to further develop my knowledge in market access.

Seagen

Katerina Afanasjeva, Project Manager - Switzerland - September 2023

What more can I say about this course other than amazing! The topics covered, the expert trainer, the interaction with the other participants and the service and support from CELforPharma, all perfect. A day well spent, thank you!

Daiichi Sankyo

Shantanu Jawla, Manager - HEOR & RWE - Germany - June 2023

This was a very well organised and comprehensive day, giving a strong overview on market access in Europe. Highly recommended for anyone new to the field or wanting to gain knowledge on the cross-European perspective.

GSK

Andy McGuffie, Government Affairs Director - United Kingdom - June 2023

What I valued most from this 1-day training was the quality of the content and expertise from the trainer, the exchanges and sharing of experiences with other participants and the good organisation and support from the CELforPharma team. These things made for a very enjoyable, insightful and engaging course experience, thank you!

Legacy Healthcare

Angelo Mello, Corporate Development Director - Switzerland - June 2023

Nick Proctor's course provides an excellent overview and introduction to key concepts in Market Access. I have many years of industry experience in medical affairs, and as my role is expanding I joined the course as an opportunity to consolidate many different ideas and principles (and abbreviations!) which I have heard before, but did not have fully clarified for how market access fits in the industry, as well as key ideas which are important for the function. In reality, the course exceeded my expectations - the content is excellently structured, and Nick provides a balance between an overview of the key ideas, and details for key markets as an example for how approaches can differ depending on stakeholders and country structure. The closing session on cross-functional process and strategy is also really helpful to connect the ideas with my experience in other parts of the industry. Super helpful, thank you Nick!

Novartis

Rachel Cruickshank, Medical Operations Lead - Spain - June 2023

Very comprehensive overview of the payer landscape in Europe - I would highly recommend!

Osprey Health Consulting

Peirce Treacy, Strategic Consultant - United Kingdom - March 2023

I would absolutely recommend this course to someone transitioning into Market Access like I am. I gained so much by attending including definitions of concepts I had never dealt with before. In addition to the content and the expertise of Nick, we also had many great opportunities to ask questions freely and learn from the other attendees experiences. THANK YOU!!

Daiichi Sankyo

Andrea Gonzalo González, Pricing Manager - Germany - June 2023

This course is a great intro and overall dive into the basics of Market Access. It was a day full of engagement with lots of valuable learning from the content presented as well as the shared experiences from Nick and the other participants.

Daiichi Sankyo

Johana Oshiro, Expert V&A Business Management - Germany - June 2023

Extremely clear and engaging course. I'll happily recommend it to my colleagues who are also very much interested in grasping general concepts of market access. Thanks to Nick and also to CELforPharma for their kind support throughout the day

Novartis

Anna Jedrusik, Senior Manager, Public Affairs, Region Europe - Switzerland - December 2022

Good time with excellent overview of reimbursement systems in EU5.

Nutricia

Artur Krzyżanowski, Medical Affairs & Market Access Director - Poland - December 2022

Very relevant and engaging course by Nick Proctor - I can highly recommend the course to HEOR and Access professionals working in global roles.

Novo Nordisk

Sara Larsen, Senior Global HEOR Manager - Denmark - October 2022

Nick gave a very relevant overview of what matters to payers across Europe. Very intense and insightful!

Biotest

Jonas Alfermann, Head of Market and Pricing Insights - Germany - October 2022

Everything you always wanted to know about market access strategies (but were afraid to ask) can be found in Nick's great course!

EFPIA

François Bouvy, Executive Director Economic and Social Affairs - Belgium - March 2022

I now have a better understanding of what market access really is thanks to Nick’s clarifications of terms and definitions on what is a very complex topic. I know now what the dynamics and differences between countries are. I loved having such a diverse group on the course to also get their input from their countries. Thank you.

Dr. Schär

Melanie Steinmair, Medical Affairs Manager Renal Nutrition - Italy - March 2022

The course is an excellent option to learn about the access function in one day from a company perspective, as well as the behaviours of the different decision maker archetypes that drive decisions in access to medicines in Europe.

Vertex Pharmaceuticals

Fernando Albertos Martínez, International Pricing and Market Access Associate Director - Spain - March 2022

Excellent course for anybody looking to get an introduction into market access pathways in the EU5 countries.

EFPIA

Mihai Rotaru, Senior Manager, Market Access - Belgium - March 2022

A very well put together course by Nick to give an overview of EU market access in just 1 day. This cannot be easy as there is plenty to learn and talk about! It is broken down with enough detail but not too much that it distracts from the bigger picture and the variation of MA landscapes.

Insmed

Joe Willard, Associate Director MA UK&I - United Kingdom - March 2022

Fantastic introduction - highly appreciated for a 'newbie'.

EFPIA

Sophie Millar, Public Affairs Manager - Belgium - March 2022

I came away from the course with an excellent overview of Market Access in pharma. Nick demonstrated a rather deep knowledge of all topics covered during the training and I gained lots of valuable insights condensed into 1 day. Also, excellent organisation and communication by CELforPharma. Many thanks.

Bayer

Jens Scheidtmann, Lead Data Architect Market Access - Germany - December 2021

This course provides a very good overview of the market access landscape and players in Europe. Nick is definitely an expert in his field and did a great job presenting. We got enough opportunities to interact with the other participants, which provided a variety of different perspectives due to our different backgrounds. Thanks.

Santen

Nadiya Deferne, Public Affairs Lead - Switzerland - December 2021

Nick really added great value to the day by giving us a detailed look at the key European market access processes as well as a good insight into the cross-functional process for optimal access. He is a very good speaker and engaging presenter with extensive knowledge used to answer any and all questions. The CELforPharma staff were incredibly helpful and very much on top of everything. Thank you both so much!

Novo Nordisk

Yannick Van Ballaer, Project Manager - Switzerland - October 2021

Nick was very good at explaining everything and gave us a nice general overview of the Market Access process in Europe. The content was perfectly aligned with my expectations. Thanks to both Nick and CELforPharma!

Bluepharma

Ana Patricia Rei, Head of Portfolio Management - Portugal - October 2021

Nick has real experience which added lots of value to the course because it meant he was able to give us concrete details and examples on major markets. He really did a great job presenting. Thank you. I would like to also say thank you for the service from CELforPharma which was indeed excellent before, during and after the course.

Tecnimede

Miguel Ruas Da Silva, Vice-President - Portugal - October 2021

Very good course, delivered by a knowledgeable expert.

Yakumed

Mohamed Oubihi, CEO - United Kingdom - October 2021

The expert trainer Nick gives you a good insight into the possible difficulties of successful market access in different countries and what to keep in mind to avoid those difficulties as much as possible. I want to thank Nick for a great training and thank CELforPharma for being so helpful to make sure I was set and ready to attend and ensure all ran smoothly on the day.

AOP Orphan

Simone Klingenbrunner, Business Development Specialist - Austria - October 2021

The course gave a nicely detailed coverage of the different MA approaches across Europe with an excellent and knowledgeable presenter. Thanks to Nick and the CELforPharma team. It was a very enjoyable course day!

Takeda

Sam Williams, Tender & Pricing Manager - United Kingdom - June 2021

Having transitioned from an affiliate to a global role, this was the type of EU5 country-comparisons and discussions I was looking for. The content and the moderation enables detection of patterns regarding key new developments between countries. One of my favourite aspects was the interactive group discussions, polls and quizzes. A good group and enjoyable course. Thank you.

Ferring

Sebastian Vosgerau, Associate Dir. Global Market Access & Strategic Pricing - Germany - June 2021

For those who wish to be initiated to Market Access, I highly recommend this course. It is clear, well delivered, allows great interaction and is well organised.

argenx

Adeline Boucher, Head of EU Regulatory - Belgium - June 2021

Great overview for a quite complex topic, in just one day.

Janssen

Mohamed Mokhtar, Marketing Lead Gastro - Germany - June 2021

Nick was a very considerate trainer, who took a complex multi-dimensional topic to a simple level, which was straightforward to understand. It helped establish a base line level of understanding of the key concepts in Market Access and Payer negotiations across Europe. Thank you.

BMS

Emma Bowden, Head of Corporate Affairs, EU Cluster - United Kingdom - March 2021

The course was very well organised. During the course I experienced a nice atmosphere, in which I could ask any question. The expert really knows what he is talking about and was able to answer all our questions in an even more than sufficient way.

Bayer

Fabian Deck, Solution Engineer for Market Access - Germany - March 2021

It was a great session, very well organised! The expert instructor navigates successfully - in a simple and clear way - the reasons for increasing payer control mechanisms across EU and their emerging needs.

UCB

Panagiotis Fournaros, Market Access Performance Excellence Lead - Greece - March 2021

An excellent introduction to the intricacies and considerations of market access. Particularly good at highlighting the cross-functional requirement for successful market access. A good introductory course for those entering into the field or a refresher to those with experience needing an update.

Kowa

Rod Coombs, President & Director - United Kingdom - March 2021

I really enjoyed Nick as a presenter and his knowledge. He had a very humorous way of portraying the info and answering the questions.

Bayer

Sarah Koytcheva, PI2 Pricing Manager - Germany - March 2021

People attending this course are typically also interested in the below courses. 

Need help to find the right course? Email Inge Cornelis (Director, Client & Product Projects) or call +32 473 65 15 77

Course Details

Dates & Locations

3 October 2025

Live online (CET timing)

Register

10 December 2025

Live online (CET timing)

Register

Upcoming Session

3 October 2025, Live online (CET timing)

Early bird € 1 470

(until 29/08/2025)

 (Full fee € 1 670)

Prices are excl. VAT

THE CONTENT

Market access is essential for brand success yet achieving it in Europe’s complex and evolving healthcare systems is far from straightforward. Each country has its own structure, payer expectations, and decision-making processes. Navigating these effectively requires careful planning and cross-functional collaboration from Phase II onwards.

This course is designed to demystify market access in Europe. You will receive clear schematic overviews of the market access systems in Europe’s major markets (EU4+UK), providing you with a reliable reference tool for your day-to-day work. The content will help you understand how access decisions are made and what is required to optimise market access from early development onwards.
 

I gained a solid understanding of the material and deeper insights into the top 5 EU countries, including payer evaluations and what their needs are per country. Nick was a very thoughtful teacher who answered all my questions and was patient and very knowledgeable on each topic. Recommended!

Johnson & Johnson

Neha D. - USA - March 2025


Hear directly from expert Nick Proctor why you should attend this course:


THE EXPERT

Dr Nick Proctor has been a trusted advisor on market access to the pharmaceutical industry for over 25 years, leading pricing, reimbursement, and market access projects for many of the world’s top pharmaceutical brands.

  • He is a Partner at Access Infinity, a specialist pharma market access and pricing consultancy.

  • He has a strong background in pricing, evidence synthesis, health economics and outcomes research, as well as experience working with payers in all major developed and emerging international health markets.

  • A CELforPharma faculty member since 2015, Nick is a very passionate trainer. He actively engages participants in discussions and is highly experienced in leading interactive sessions.
     

A clear helicopter view of the Market Access environment in Europe! I recommend this course to anyone seeking a better understanding of the Market Access process and how payers assess drugs. Nick is a great expert and trainer.

Molteni Farmaceutici

Filippo Mannelli, Portfolio & Business Development Manager - Italy - March 2025


THE AUDIENCE & INTERACTIVE LEARNING FORMAT

If you contribute to optimising market access for new chemical entities or innovator drugs, this course is designed for you. It is particularly relevant for professionals working in Market Access, Medical Affairs, Marketing, Clinical Development, and Health Outcomes.

You will benefit from:

  • Expert-led explanations of European market access systems, with clear schematic overviews

  • Opportunities to ask your specific questions and receive personalised guidance

  • Peer learning through open discussion and shared experiences

This format ensures you leave with a solid understanding of how market access works across Europe and how payers assess new drugs.

If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend. 

  1. The patterns in pricing & reimbursement systems and processes in France, Germany, Italy, Spain and the UK.

  2. Market access challenges and opportunities in these countries.

  3. How to differentiate between different categories of payers.

  4. Payer archetypes and the drivers of their decision-making processes.

  5. The market access plan and process, and the contributions of internal stakeholders across functions.

  6. The types of Managed Entry Agreements used by payers and pharma to mitigate risk.

Course agenda

 

This course was well-structured and informative, and Nick was able to provide answers to all questions. I also liked the cross-country attendance and interactions with the other participants.

Eisai

Chiara Castellarin, Associate Brand Director EMEA - United Kingdom/Europe - March 2025

 

 

 

Welcome & Introductions (~30 min)
Demystifying Market Access (~1 h)
  • What do we mean by market access? What does it encompass?
  • Why and how did market access evolve?
  • What are the concerns of market access decision-makers?
Understanding Payer Archetypes (~2 h)
  • What are the useful ways of thinking about different types of payers?
  • The three universal drivers of payer value
  • The three approaches to archetyping payers, illustrated by examples in Europe
  • The strengths and weaknesses of different payer archetype approaches
  • How to decide which approach to use in a particular situation
  • The common missteps and challenges when applying payer archetypes
  • How to successfully use payer archetypes to plan evidence development
Lunch Break
France & Germany (~1 h 15 min)
  • Understanding national payer assessment processes and implications in France and Germany
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries
Italy & Spain (~45 min)
  • Understanding national payer assessment processes and implications in Italy and Spain
  • Critical stakeholders in these countries
  • Market access challenges and opportunities in these countries
UK (~30 min)
  • Understanding national payer assessment processes and implications in the UK
  • Critical stakeholders in the UK
  • Market access challenges and opportunities in the UK
A Cross-functional Process for Optimal Access (~45 min)
  • The market access plan and process as of Phase II
  • Milestones and the critical contributions of internal stakeholders
  • Different types of Managed Entry Agreements illustrated by real-world examples
Final Q&A (~15 min)

 

Download Brochure

 

Complete the below form to download the full course brochure. It outlines the detailed agenda, learning outcomes, expert info and some testimonials from past participants.

 

 

UPCOMING DATES & FORMATS - FEES

3 October 2025

Live online (CET timing)

Early bird € 1 470

(until 29/08/2025)

(Full fee € 1 670)

10 December 2025

Live online (CET timing)

Early bird € 1 470

(until 07/11/2025)

(Full fee € 1 670)

 


TIMING & LOCATION

  • Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).

  • Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).

  • Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.

All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .

 

GROUP DISCOUNTS

Team discounts can be offered to 2 or more delegates from the same company.

Email Annelies Swaan, Director Business Operations, for more details. 

 

HOW TO REGISTER

  • Click the green “Register” button on your preferred course session.
    The registration wizard will guide you through the process.

  • Alternatively, download the offline registration form and send the completed form to Annelies Swaan.

 

PAYMENT OPTIONS

  • Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).

  • Bank Transfer: Details provided with your invoice.

For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.

 

INCLUDED IN THE REGISTRATION FEE

  • Access to a highly interactive, small-group online course (max 20 participants)

  • Course materials in both digital and hard copy format

  • Certificate of attendance signed by the experts and CELforPharma

 

VAT INFORMATION

Prices exclude VAT. VAT application depends on course format and your location:

  • Face-to-Face in Belgium: 21% Belgian VAT applies

  • Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.

 

TRANSFER & CANCELLATION POLICY

Flexible Transfer

If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.

Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.

Registration Cancellation

  • Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.

  • Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.

  • More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.

If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
 

The average Recommendation Score from participants of the last session was 

9,4/10!

 

 

Testimonials from past participants:

Very comprehensive information, including background and historical explanations.

Bayer Vital

Valeska Irrgang, Portfolio Strategist Europe - Germany - March 2025

A clear helicopter view of the Market Access environment in Europe! I recommend this course to anyone seeking a better understanding of the Market Access process and how payers assess drugs. Nick is a great expert and trainer.

Molteni Farmaceutici

Filippo Mannelli, Portfolio & Business Development Manager - Italy - March 2025

This course was well-structured and informative, and Nick was able to provide answers to all questions. I also liked the cross-country attendance and interactions with the other participants.

Eisai

Chiara Castellarin, Associate Brand Director EMEA - United Kingdom/Europe - March 2025

I gained a solid understanding of the material and deeper insights into the top 5 EU countries, including payer evaluations and what their needs are per country. Nick was a very thoughtful teacher who answered all my questions and was patient and very knowledgeable on each topic. Recommended!

Johnson & Johnson

Neha D. - USA - March 2025

The Understanding Pharma Market Access & Payers in Europe course was a great way to enhance the understanding of access principles for those new to or outside the field of market access. The course was well-structured, and participants shared valuable real-life insights from their various companies and functions.

Novartis

Sonia Adda, AD, Breast Cancer Marketing - Switzerland - December 2024

As someone who has been working in pharma for the past 10 years but not in the market access space, this course gave me a rich understanding of the market access process, its complexities, and its role in enabling pharmaceutical products to reach patients. Thank you!

Ferring

Sonia Johnston, VP HR (Global Science & Medical Organisation) - Switzerland - December 2024

A very engaging course that is relevant to a broad audience, both within the market access function and outside of it. Highly recommended!

Vertex

Yana Berezovskaya, Senior Medical Science Liaison - United Kingdom - December 2024

Comprehensive, high-level view of Market Access, in particular a focus on payer archetypes and what motivates them. This course really does explain the why behind many Market Access-related decisions. I was glad to have the live course where I could ask questions in real-time and hear from others. Thank you!

CSL

Sarah Hamlett, Senior Director, Global Head of Payer Partnerships - Switzerland - October 2024

Interesting course where I had the opportunity to learn about the several routes of access in Europe in the different countries.

FarmaMondo

Luigi Bocchetti, Market Access Manager - Italy - October 2024

Useful for putting ourselves in the shoes of a payer!

Almirall

Rituparna Banerjee, Global Market Access Senior Manager - Spain - October 2024

Nick was great! Very informative and helpful session!

Medreich

Ruchika Raisinghani, Business Development Manager - United Kingdom - October 2024

I recently completed the "Understanding Pharma Market Access & Payers in Europe" course, and I must say it exceeded my expectations. The explanations provided were very clear, accompanied by relevant examples that made the complex concepts easy to grasp. The course offered valuable insights into the intricacies of pharma market access and payer dynamics in Europe. I highly recommend it to anyone looking to enhance their understanding of this critical aspect of the pharmaceutical industry.

EFPIA

Giacomo Borgo, Associate Director Public Affairs - Belgium - December 2023

Very informative session facilitated by an industry expert. Highly recommended if you want to know more on EU payers.

Boehringer Ingelheim

Hans Demeyere, Senior Manager Global Market Access - Germany - September 2023

Having worked in access positions for few months now, this course enabled me to structure my knowledge while filling the gaps. I recommend it for any newcomer in an Access and Pricing role.

UCB

Nicolas De Mot, Market Access Performance Lead - Belgium - September 2023

I am very pleased with the course! The information shared definitely gave me a direction on how to further develop my knowledge in market access.

Seagen

Katerina Afanasjeva, Project Manager - Switzerland - September 2023

What more can I say about this course other than amazing! The topics covered, the expert trainer, the interaction with the other participants and the service and support from CELforPharma, all perfect. A day well spent, thank you!

Daiichi Sankyo

Shantanu Jawla, Manager - HEOR & RWE - Germany - June 2023

This was a very well organised and comprehensive day, giving a strong overview on market access in Europe. Highly recommended for anyone new to the field or wanting to gain knowledge on the cross-European perspective.

GSK

Andy McGuffie, Government Affairs Director - United Kingdom - June 2023

What I valued most from this 1-day training was the quality of the content and expertise from the trainer, the exchanges and sharing of experiences with other participants and the good organisation and support from the CELforPharma team. These things made for a very enjoyable, insightful and engaging course experience, thank you!

Legacy Healthcare

Angelo Mello, Corporate Development Director - Switzerland - June 2023

Nick Proctor's course provides an excellent overview and introduction to key concepts in Market Access. I have many years of industry experience in medical affairs, and as my role is expanding I joined the course as an opportunity to consolidate many different ideas and principles (and abbreviations!) which I have heard before, but did not have fully clarified for how market access fits in the industry, as well as key ideas which are important for the function. In reality, the course exceeded my expectations - the content is excellently structured, and Nick provides a balance between an overview of the key ideas, and details for key markets as an example for how approaches can differ depending on stakeholders and country structure. The closing session on cross-functional process and strategy is also really helpful to connect the ideas with my experience in other parts of the industry. Super helpful, thank you Nick!

Novartis

Rachel Cruickshank, Medical Operations Lead - Spain - June 2023

Very comprehensive overview of the payer landscape in Europe - I would highly recommend!

Osprey Health Consulting

Peirce Treacy, Strategic Consultant - United Kingdom - March 2023

I would absolutely recommend this course to someone transitioning into Market Access like I am. I gained so much by attending including definitions of concepts I had never dealt with before. In addition to the content and the expertise of Nick, we also had many great opportunities to ask questions freely and learn from the other attendees experiences. THANK YOU!!

Daiichi Sankyo

Andrea Gonzalo González, Pricing Manager - Germany - June 2023

This course is a great intro and overall dive into the basics of Market Access. It was a day full of engagement with lots of valuable learning from the content presented as well as the shared experiences from Nick and the other participants.

Daiichi Sankyo

Johana Oshiro, Expert V&A Business Management - Germany - June 2023

Extremely clear and engaging course. I'll happily recommend it to my colleagues who are also very much interested in grasping general concepts of market access. Thanks to Nick and also to CELforPharma for their kind support throughout the day

Novartis

Anna Jedrusik, Senior Manager, Public Affairs, Region Europe - Switzerland - December 2022

Good time with excellent overview of reimbursement systems in EU5.

Nutricia

Artur Krzyżanowski, Medical Affairs & Market Access Director - Poland - December 2022

Very relevant and engaging course by Nick Proctor - I can highly recommend the course to HEOR and Access professionals working in global roles.

Novo Nordisk

Sara Larsen, Senior Global HEOR Manager - Denmark - October 2022

Nick gave a very relevant overview of what matters to payers across Europe. Very intense and insightful!

Biotest

Jonas Alfermann, Head of Market and Pricing Insights - Germany - October 2022

Everything you always wanted to know about market access strategies (but were afraid to ask) can be found in Nick's great course!

EFPIA

François Bouvy, Executive Director Economic and Social Affairs - Belgium - March 2022

I now have a better understanding of what market access really is thanks to Nick’s clarifications of terms and definitions on what is a very complex topic. I know now what the dynamics and differences between countries are. I loved having such a diverse group on the course to also get their input from their countries. Thank you.

Dr. Schär

Melanie Steinmair, Medical Affairs Manager Renal Nutrition - Italy - March 2022

The course is an excellent option to learn about the access function in one day from a company perspective, as well as the behaviours of the different decision maker archetypes that drive decisions in access to medicines in Europe.

Vertex Pharmaceuticals

Fernando Albertos Martínez, International Pricing and Market Access Associate Director - Spain - March 2022

Excellent course for anybody looking to get an introduction into market access pathways in the EU5 countries.

EFPIA

Mihai Rotaru, Senior Manager, Market Access - Belgium - March 2022

A very well put together course by Nick to give an overview of EU market access in just 1 day. This cannot be easy as there is plenty to learn and talk about! It is broken down with enough detail but not too much that it distracts from the bigger picture and the variation of MA landscapes.

Insmed

Joe Willard, Associate Director MA UK&I - United Kingdom - March 2022

Fantastic introduction - highly appreciated for a 'newbie'.

EFPIA

Sophie Millar, Public Affairs Manager - Belgium - March 2022

I came away from the course with an excellent overview of Market Access in pharma. Nick demonstrated a rather deep knowledge of all topics covered during the training and I gained lots of valuable insights condensed into 1 day. Also, excellent organisation and communication by CELforPharma. Many thanks.

Bayer

Jens Scheidtmann, Lead Data Architect Market Access - Germany - December 2021

This course provides a very good overview of the market access landscape and players in Europe. Nick is definitely an expert in his field and did a great job presenting. We got enough opportunities to interact with the other participants, which provided a variety of different perspectives due to our different backgrounds. Thanks.

Santen

Nadiya Deferne, Public Affairs Lead - Switzerland - December 2021

Nick really added great value to the day by giving us a detailed look at the key European market access processes as well as a good insight into the cross-functional process for optimal access. He is a very good speaker and engaging presenter with extensive knowledge used to answer any and all questions. The CELforPharma staff were incredibly helpful and very much on top of everything. Thank you both so much!

Novo Nordisk

Yannick Van Ballaer, Project Manager - Switzerland - October 2021

Nick was very good at explaining everything and gave us a nice general overview of the Market Access process in Europe. The content was perfectly aligned with my expectations. Thanks to both Nick and CELforPharma!

Bluepharma

Ana Patricia Rei, Head of Portfolio Management - Portugal - October 2021

Nick has real experience which added lots of value to the course because it meant he was able to give us concrete details and examples on major markets. He really did a great job presenting. Thank you. I would like to also say thank you for the service from CELforPharma which was indeed excellent before, during and after the course.

Tecnimede

Miguel Ruas Da Silva, Vice-President - Portugal - October 2021

Very good course, delivered by a knowledgeable expert.

Yakumed

Mohamed Oubihi, CEO - United Kingdom - October 2021

The expert trainer Nick gives you a good insight into the possible difficulties of successful market access in different countries and what to keep in mind to avoid those difficulties as much as possible. I want to thank Nick for a great training and thank CELforPharma for being so helpful to make sure I was set and ready to attend and ensure all ran smoothly on the day.

AOP Orphan

Simone Klingenbrunner, Business Development Specialist - Austria - October 2021

The course gave a nicely detailed coverage of the different MA approaches across Europe with an excellent and knowledgeable presenter. Thanks to Nick and the CELforPharma team. It was a very enjoyable course day!

Takeda

Sam Williams, Tender & Pricing Manager - United Kingdom - June 2021

Having transitioned from an affiliate to a global role, this was the type of EU5 country-comparisons and discussions I was looking for. The content and the moderation enables detection of patterns regarding key new developments between countries. One of my favourite aspects was the interactive group discussions, polls and quizzes. A good group and enjoyable course. Thank you.

Ferring

Sebastian Vosgerau, Associate Dir. Global Market Access & Strategic Pricing - Germany - June 2021

For those who wish to be initiated to Market Access, I highly recommend this course. It is clear, well delivered, allows great interaction and is well organised.

argenx

Adeline Boucher, Head of EU Regulatory - Belgium - June 2021

Great overview for a quite complex topic, in just one day.

Janssen

Mohamed Mokhtar, Marketing Lead Gastro - Germany - June 2021

Nick was a very considerate trainer, who took a complex multi-dimensional topic to a simple level, which was straightforward to understand. It helped establish a base line level of understanding of the key concepts in Market Access and Payer negotiations across Europe. Thank you.

BMS

Emma Bowden, Head of Corporate Affairs, EU Cluster - United Kingdom - March 2021

The course was very well organised. During the course I experienced a nice atmosphere, in which I could ask any question. The expert really knows what he is talking about and was able to answer all our questions in an even more than sufficient way.

Bayer

Fabian Deck, Solution Engineer for Market Access - Germany - March 2021

It was a great session, very well organised! The expert instructor navigates successfully - in a simple and clear way - the reasons for increasing payer control mechanisms across EU and their emerging needs.

UCB

Panagiotis Fournaros, Market Access Performance Excellence Lead - Greece - March 2021

An excellent introduction to the intricacies and considerations of market access. Particularly good at highlighting the cross-functional requirement for successful market access. A good introductory course for those entering into the field or a refresher to those with experience needing an update.

Kowa

Rod Coombs, President & Director - United Kingdom - March 2021

I really enjoyed Nick as a presenter and his knowledge. He had a very humorous way of portraying the info and answering the questions.

Bayer

Sarah Koytcheva, PI2 Pricing Manager - Germany - March 2021

Dates & Locations

3 October 2025

Live online (CET timing)

Register

10 December 2025

Live online (CET timing)

Register